Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 8/20 | 0.39 |
| ▸ | CES1 | P23141 | 5/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MLYCD | O95822 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL712857 | 0.94 | EPHX1 (0.50) | EPHX1FAAHCES1CES2MEN1 | |
| SCHEMBL28224073 | 0.93 | EPHX1 (0.53) | EPHX1FAAHCES1CES2MEN1 | |
| SCHEMBL28253440 | 0.88 | EPHX1 (0.41) | EPHX1CTSKCA2FAAHCES1 | |
| SCHEMBL24371436 | 0.78 | EPHX1 (0.44) | EPHX1CTSKCA1CA2FAAH | |
| SCHEMBL8178933 | 0.78 | NOD1 (0.49) | EPHX1CTSKCA1CA2 | |
| SCHEMBL1236443 | 0.78 | NOD1 (0.49) | EPHX1CTSKCA1CA2 | |
| SCHEMBL1504690 | 0.78 | CA2 (0.37) | EPHX1CA2MEN1KMT2AALDH1A1 | |
| SCHEMBL3080842 | 0.77 | EPHX1 (0.43) | EPHX1CTSKCA1CA2FAAH | |
| SCHEMBL564162 | 0.77 | EPHX1 (0.43) | EPHX1CTSKCA1CA2FAAH | |
| SCHEMBL7045874 | 0.76 | MLYCD (0.57) | EPHX1CA1FAAHCES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090269734-A1 | METHOD FOR DETERMINATION OF RECOGNITION SPECIFICITY OF VIRUS FOR RECEPTOR SUGAR CHAIN | SHIZUOKA PREFECTURAL UNIVERSITIES CORPORATION, NATIONAL UNIVERSITY CORPORATION SHIZUOKA | 2009-10-29 | — | — | US | disclosed |
| US-20090181362-A1 | METHOD FOR DETERMINATION OF RECOGNITION SPECIFICITY OF VIRUS FOR RECEPTOR SUGAR CHAIN | NATIONAL UNIVERSITY CORPORATION SHIZUOKA UNIVERSITY (JP) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181362-A1 | METHOD FOR DETERMINATION OF RECOGNITION SPECIFICITY OF VIRUS FOR RECEPTOR SUGAR CHAIN | SIGLEC7, SIGLEC9, NEU4 | EPHX1 3950/4885CTSK 3054/4885CA1 1187/4885 |
| US-20090269734-A1 | METHOD FOR DETERMINATION OF RECOGNITION SPECIFICITY OF VIRUS FOR RECEPTOR SUGAR CHAIN | SIGLEC7, SIGLEC9, NEU4 | EPHX1 3910/4885CTSK 2986/4885CA1 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.